Language Select
Varian Logo

Press Releases

April 26, 2018
Varian (NYSE: VAR) today announced Hospital Alemão Oswaldo Cruz in São Paulo, Brazil will be the first hospital in Brazil to install a Halcyon™ treatment system. Scheduled to be installed in... Read more
April 25, 2018
Varian (NYSE: VAR) today announced it has signed an agreement with the Stockholm City Council to provide equipment and related services to the radiation therapy department of the New Karolinska... Read more
April 25, 2018
Second Quarter 2018 Summary Revenues of $730 million grew 10 percent, or 6 percent in constant currency Oncology gross orders grew 5 percent, or 1 percent in constant currency GAAP operating... Read more
April 20, 2018
Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian TrueBeam®, Edge® and Clinac® C-series medical linear... Read more
April 19, 2018
Varian (NYSE: VAR) today announced it will be showcasing the expanded imaging and treatment capabilities of the Halcyon™ system and the new version of the Velocity™ cancer imaging software,... Read more
April 19, 2018
Varian (NYSE: VAR) today announced it is incorporating new imaging technologies in the Halcyon™ 2.0 treatment system to expand its capabilities and ability to deliver high quality cancer care... Read more
April 18, 2018
Varian (NYSE: VAR) today announced it received the "Best After-Sales Service Performance Award for Radiotherapy Products" in the annual Chinese Medical Devices Industry Data and After-Sales... Read more
April 09, 2018
Varian (NYSE: VAR) today announced a new version of its Velocity™ cancer imaging software which includes Rapidsphere™, a module for Y90 Selective Internal Radiation Therapy (SIRT) dosimetry... Read more
March 27, 2018
Varian (NYSE: VAR) today announced customers using Varian Eclipse™ treatment planning software placed the highest in the overall category in the first ever World Championships of Treatment... Read more
March 20, 2018
Varian (NYSE: VAR) announced PTC St. Petersburg Center of Nuclear Medicine of the Sergey Berezin Medical Institute successfully completed its first pediatric patient treatment with the Varian... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]